A few retrospective and review studies suggest a major risk of thromboembolic complications in COVID-19 patients, causing many to converge on the hypothesis that general endothelial dysfunction and activation of the coagulation system disrupts immune, renin-angiotensin-aldosterone, and thrombotic balance [9–11]. This evidence concerns the gene REN and COVID-19.